2022
DOI: 10.3390/molecules28010247
|View full text |Cite
|
Sign up to set email alerts
|

Biomaterials Based on Chitosan and Its Derivatives and Their Potential in Tissue Engineering and Other Biomedical Applications—A Review

Abstract: In the times of dynamically developing regenerative medicine, more and more attention is focused on the use of natural polymers. This is due to their high biocompatibility and biodegradability without the production of toxic compounds, which means that they do not hurt humans and the natural environment. Chitosan and its derivatives are polymers made most often from the shells of crustaceans and are biodegradable and biocompatible. Some of them have antibacterial or metal-chelating properties. This review arti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 102 publications
0
14
0
Order By: Relevance
“…CH is able to stimulate the differentiation of multipotent mesenchymal progenitor cells and growth factor such as FGF and TGFβ1, increasing fibroblast proliferation. 2,7,18 Ca(OH) 2 been the material of choice for direct pulp capping. However, this material has some deficiencies.…”
Section: Discussionmentioning
confidence: 99%
“…CH is able to stimulate the differentiation of multipotent mesenchymal progenitor cells and growth factor such as FGF and TGFβ1, increasing fibroblast proliferation. 2,7,18 Ca(OH) 2 been the material of choice for direct pulp capping. However, this material has some deficiencies.…”
Section: Discussionmentioning
confidence: 99%
“…However, chitosan by itself has a weak affinity to antibiotic drugs like levofloxacin; thus, its application as a DDS for levofloxacin is still limited. Chitosan by itself serves as a prospective DDS for variable types of therapeutics, such as antiviral drugs and materials for tissue engineering [ 11 , 12 , 13 ], as well as in combination with other DDS like niosomes and liposomes [ 9 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…[1] These biomaterials play a key role as tissue replacement therapy during bone architectural damage in diseases like rheumatoid arthritis (RA). [2] Bone erosion and demineralization associated with RA are attributed to enhanced osteoclast activitycausing bone resorption-and inhibition of osteoblast activity-inhibiting new bone formation. These characteristics further attribute to bone fracture, leading to disability and thus impacting the quality of life.…”
Section: Introductionmentioning
confidence: 99%